Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy with PBPC Support in Metastatic Breast Cancer
NCT00003392Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Sep 1997
- Primary completion
- Aug 2002
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, Paclitaxel Micelles for Injection, carboplatin, melphalan, filgrastim in breast cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Sep 1997; status: completed.
02
Drugs
cyclophosphamidePaclitaxel Micelles for Injectioncarboplatinmelphalanfilgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003392.